Analysis of State-Level Drug Pricing Transparency Laws in the United States
Author(s) -
Martha S. Ryan,
Neeraj Sood
Publication year - 2019
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2019.12104
Subject(s) - transparency (behavior) , supply chain , drug prices , business , medicaid , state (computer science) , drug , public economics , economics , law , marketing , pharmacology , medicine , political science , computer science , algorithm , health care
This cross-sectional study examines state drug pricing transparency laws enacted to increase supply chain price transparency in the United States.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom